Details for New Drug Application (NDA): 021046
✉ Email this page to a colleague
NDA 021046 describes CELEXA, which is a drug marketed by Forest Labs and Abbvie and is included in two NDAs. It is available from one supplier. Additional details are available on the CELEXA profile page.
The generic ingredient in CELEXA is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.
The generic ingredient in CELEXA is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.
Summary for 021046
| Tradename: | CELEXA |
| Applicant: | Forest Labs |
| Ingredient: | citalopram hydrobromide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021046
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | EQ 10MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 22, 1999 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
